A股異動 | 晶盛機電(300316.SZ)大漲逾9% 目前自主研發的碳化硅單晶爐已經實現銷售
格隆匯9月17日丨晶盛機電(300316.SZ)大漲逾9%,報32.71元,股價再創上市以來新高,總市值420億元。有投資者昨日在互動平台向晶盛機電提問, 為了迎接第三代半導體產業發展,公司是否有這方面的技術儲備和投資嗎。公司回答表示,公司較早啟動了對碳化硅等第三代半導體材料設備的研發。目前自主研發的碳化硅單晶爐已經實現銷售,外延設備已經取得客户技術驗證通過,在行業內奠定了較好的基礎和聲譽。公司將繼續加大研發力度,充分發揮在半導體裝備和精密製造領域的技術優勢,持續拓展碳化硅等第三代半導體材料裝備。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.